IU Simon Cancer Center Teams with OncLive in Strategic Alliance Partnership

PLAINSBORO, N.J. (PRWEB) March 03, 2015 -- OncLive® and Indiana University Melvin and Bren Simon Cancer Center have joined forces to share news about the center’s research and education programs, OncLive announced today. The collaboration is part of OncLive’s Strategic Alliance Partnership initiative.

Through the new alliance, OncLive’s editorial and marketing teams will partner with the IU Simon Cancer Center, a National Cancer Institute-designated cancer center, to highlight accomplishments. They include the center’s recent National Institutes of Health grant to study cervical cancer in Kenyan women and the discovery of a simple blood test that could help diagnose pancreatic cancer.

“The IU Simon Cancer Center is conducting internationally recognized work as it fights a variety of cancers,” said Mike J. Hennessy Jr., senior vice president, oncology & specialty pharmacy, which includes OncLive, at Michael J. Hennessy Associates, Inc. “We too are committed to fighting cancer, and getting the news out about programs like those at the IU Simon Cancer Center is an essential component of the battle.”

The IU Simon Cancer Center’s researchers have made protocol-defining discoveries that have changed the way doctors treat testicular cancer, breast cancer, gastrointestinal cancer, genitourinary cancer, leukemia, multiple myeloma, thymoma and thymic carcinomas and thoracic cancer. Its more than 200 scientists conduct research in five different programs. The goals of those programs range from understanding the molecular changes that cause cancer to developing targeted therapies to prevent and treat the disease.

“The physician scientists at the IU Simon Cancer Center are dedicated to finding better ways to prevent, detect and treat cancer,” said Patrick Loehrer Sr., M.D., director of the IU Simon Cancer Center. “We look forward to OncLive helping to share our story of how our researchers are making a difference against cancer.”

About OncLive

OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News and Contemporary Oncology. OncLive offers oncology professionals resources and information they need to provide the best care for their patients. Intellisphere, LLC, a leading provider of healthcare publishing, research and education, is part of the Michael J. Hennessy Associates, Inc. (MJH) family of businesses, based in Plainsboro, N.J. MJH also includes the acclaimed CURE Media Group, which combines science and humanity to make cancer understandable. Its flagship product is CURE™ magazine, the largest consumer publication in the U.S. focused entirely on cancer, reaching cancer patients, cancer centers and advocacy groups. To learn more, please visit http://www.OncLive.com.

About the Indiana University Melvin and Bren Simon Cancer Center

The Indiana University Melvin and Bren Simon Cancer Center is the only National Cancer Institute (NCI)-designated cancer center in Indiana that provides patient care. The NCI designation places the IU Simon Cancer Center in an elite group of 68 cancer centers across the country that focus on the rapid translation of research discoveries to directly benefit people with cancer. The mission of the IU Simon Cancer Center is to decrease the mortality and suffering from cancer by conducting outstanding translational research, providing excellence in education, and by delivering high quality patient-centered care. To learn more, please visit Indiana University Melvin and Bren Simon Cancer Center.

###

Media Contacts

For OncLive: Becky Taylor, 609.240.6886, becky(AT)btaylorpa.com

For Indiana University Melvin and Bren Simon Cancer Center: Michael Schug, 317.278.0953, maschug(AT)iupui.edu